Danhong Liu
Changsha, 410208, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Naotaifang Formula Suppresses Ferroptosis by Ameliorating Mitochondrial Biogenesis Through the Nrf2/TFAM Pathway in Ischemic Stroke.
Journal: Current neuropharmacology
Published: August 31, 2025
Pathophysiological Mechanisms and Therapeutic Targets in Cerebral Small Vessel Disease: A Comprehensive Review.
Journal: Current neuropharmacology
Published: July 21, 2025
Efficacy and safety of Chinese medicine compound for the convalescent COVID-19 patients: Protocol of a multi-centered, randomized, double-blinded, placebo-controlled clinical trial.
Journal: Contemporary clinical trials communications
Published: March 10, 2025
Disulfidptosis: a new target for central nervous system disease therapy.
Journal: Frontiers in neuroscience
Published: October 20, 2024
Research progress on the Sonic Hedgehog signaling pathway in the central nervous system: Novel insights.
Journal: Neural regeneration research
Published: October 14, 2024
Crosstalk between ferroptosis and necroptosis in cerebral ischemia/reperfusion injury and Naotaifang formula exerts neuroprotective effect via HSP90-GCN2-ATF4 pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 28, 2023
Novel insight into cGAS-STING pathway in ischemic stroke: from pre- to post-disease.
Journal: Frontiers in immunology
Published: August 09, 2023
Naotaifang formula attenuates OGD/R-induced inflammation and ferroptosis by regulating microglial M1/M2 polarization through BMP6/SMADs signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 03, 2023
Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia/reperfusion injury: from pathology to therapeutic potential.
Journal: Frontiers in cellular neuroscience
Published: March 22, 2023
MiR-140 promotes the progression of intracranial aneurysms by targeting BCL2L2.
Journal: Neuroreport
Published: November 28, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026